williamssc
3 minutes ago
Invesco Ltd. reports 2,419.76% increase in ownership of AVXL / Anavex Life Sciences Corp.
On February 13, 2025 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 615,048 shares of Anavex Life Sciences Corp. (US:AVXL) valued at $6,605,616 USD as of December 31, 2024. The entity
rocioyogi
9 minutes ago
Well, nutcase Kennedy may increase the value of Elite pharmaceutical as we have a totally approved increased sized facility, which is very attractive to the future buyer, knowing they do not have to wait on, perhaps, prolonged approval situations coming in the near future, as nutcase Kennedy has alr